Ahmed glaucoma valve implantation in African American and white patients

Archives of Ophthalmology

Volumn 124, Issue 6, 2006, Pages 800-806

  Ishida, Kyoko ^a,b   Netland, Peter A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; BLEEDING; EUROPEAN AMERICAN; FOLLOW UP; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; GRAFT FAILURE; HUMAN; HYPHEMA; INTRAOCULAR PRESSURE; IRITIS; LIFE TABLE METHOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; RETINA DETACHMENT; REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANTS; HUMANS; INTRAOCULAR PRESSURE; LIFE TABLES; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 33745039174     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.6.800     Document Type: Review

References (37)

1. Wadhwa SD, Higginbotham EJ. Ethnic differences in glaucoma: prevalence, management, and outcome. Curr Opin Ophthalmol. 2005;16:101-106.
2. Racette L, Wilson MR, Zagwill LM, et al. Primary open-angle glaucoma in blacks: a review. Surv Ophthalmol. 2003;48:295-313.
3. Girkin CA. Primary open-angle glaucoma in African Americans. Int Ophthalmol Clin. 2004;44:43-60.
4. Kosoko-Lasaki O, Olivier MM. African American health disparities: glaucoma as a case study. Int Ophthalmol Clin. 2003;43:123-131.
5. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of openangle glaucoma: the Baltimore Eye Survey. JAMA. 1991;266:369-374.
6. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in East Baltimore. N Engl J Med. 1991;325:1412-1417.
7. Martin MJ, Sommer A, Gold ER, Diamond EL. Race and primary open-angle glaucoma. Am J Ophthalmol. 1985;99:383-387.
8. Wilensky JT, Gandhi N, Pan T. Racial influence in open-angle glaucoma. Ann Ophthalmol. 1978;10:1398-1402.
9. Wilson R, Richardson TM, Hertzmark E, Grant WM. Race as a risk factor for progressive glaucomatous damage. Ann Ophthalmol. 1985;17:653-659.
10. Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St Lucia, West Indies, part I: prevalence findings. Ophthalmology. 1989;96:1363-1368.
11. Leske MC, Connell AM, Schachat AP, et al. The Barbados Eye Study: prevalence of open-angle glaucoma. Arch Ophthalmol. 1994;112:821-829.
12. Quigley HA, Tielsch JM, Katz J, et al. Ratio of progression in open angle glaucoma estimated from cross sectional prevalence of visual field damage. Am J Ophthalmol. 1996;122:355-363.
13. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943-1954.
14. Grant WM, Burke JF Jr. Why do some people go blind from glaucoma? Ophthalmology. 1982;89:991-998.
15. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open-angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol. 1991;109:1090-1095.
16. Olateju SO, Ajayi AA. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers. Eye. 1999;13:758-763.
17. Netland PA, Robertson SM, Sullivan EK, et al. Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension. Adv Ther. 2003;20:149-163.
18. La Rosa FA, Gross RL, Orengo-Nania S. Central corneal thickness of Caucasians and African Americans in glaucomatous and nonglaucomatous populations. Arch Ophthalmol. 2001;119:23-27.
19. Shimmyo M, Ross AJ, Moy A, et al. Intraocular pressure, Goldmann applanation tension, corneal thickness, and corneal curvature in Caucasians, Asians, Hispanics, and African Americans. Am J Ophthalmol. 2003;136:603-613.
20. Katz IM, Hubbard WA, Getson AJ, Gould AL. Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest Ophthalmol. 1976;15:489-492.
21. Melikian HE, Liebeman TW, Leopold IH. Ocular pigmentation and pressure and outflow responses to pilocarpine and epinephrine. Am J Ophthalmol. 1971;72:70-73.
22. Beck RW, Messner DK, Much DC, et al. Is there a racial difference in physiologic cup size? Ophthalmology. 1985;92:873-876.
23. Chi T, Ritch R, Stickler D, et al. Racial difference in optic nerve head parameters. Arch Ophthalmol. 1989;107:836-839.
24. Varma R, Tielsch JM, Quigley HA, et al. Race-, age-, gender-, and refractive errorrelated differences in the normal optic disc. Arch Ophthalmol. 1994;112:1068-1076.
25. Devgan U, Yu F, Kim E, Coleman AL. Surgical undertreatment of glaucoma in black beneficiaries of Medicare. Arch Ophthalmol. 2000;118:253-256.
26. Borisuth NS, Phillips B, Krupin T. The risk profile of glaucoma filtration surgery. Curr Opin Ophthalmol. 1999;10:112-116.
27. Morris DA, Paracha MO, Shin DH, et al. Risk factors for early filtration failure requiring suture release after primary glaucoma triple procedure with adjunctive mitomycin. Arch Ophthalmol. 1999;117:1149-1154.
28. Mermoud A, Salmon JF, Murry AD. Trabeculectomy with mitomycin C for refractory glaucoma in blacks. Am J Ophthalmol. 1993;116:72-78.
29. Shin DH, Ren J, Juzych MS, et al. Primary glaucoma triple procedure in patients with primary open-angle glaucoma: the effect of mitomycin C in patients with and without prognostic factors for filtering failure. Am J Ophthalmol. 1998;125:346-352.
30. Scott IU, Greenfield DS, Schiffman J, et al. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol. 1998;116:286-291.
31. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 13: comparison of treatment outcomes within race: 10-year results. Ophthalmology. 2004;111:651-664.
32. Freedman J, Rubin B. Molteno implant as a treatment for refractory glaucoma in black patients. Arch Ophthalmol. 1991;108:1417-1420.
33. Huang MC, Netland PA, Coleman AL, et al. Intermediate clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol. 1999;127:27-33.
34. Tsai JC, Johnson CC, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma. Ophthalmology. 2003;110:1814-1821.
35. Topouzis F, Coleman AL, Choplin N, et al. Follow-up of the original cohort with the Ahmed Glaucoma Valve implant. Am J Ophthalmol. 1999;128:198-204.
36. Nouri-Mahdavi K, Caprioli J. Evaluation of the hypertensive phase after insertion of the Ahmed Glaucoma Valve. Am J Ophthalmol. 2003;136:1001-1008.
37. Ayyala RS, Zurakowski D, Monshizadeh R, et al. Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg Lasers. 2002;33:94-101.